Testing effectiveness (Phase 2)WithdrawnNCT00003786What this trial is testingIrofulven in Treating Patients With Metastatic or Recurrent Colorectal CancerWho this might be right forColorectal Cancer University of Chicago
Early research (Phase 1)Ended earlyNCT06625515What this trial is testingFirst-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined CancersWho this might be right forAdvanced Solid TumorsBreast Cancer RecurrentColorectal Cancer Metastatic+3 more Accent Therapeutics 17
Early research (Phase 1)Looking for participantsNCT06657144What this trial is testingCHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid TumorsWho this might be right forMetastatic Solid TumorAdvanced Solid Tumor Coherus Oncology, Inc. 154
Large-scale testing (Phase 3)Study completedNCT00062426What this trial is testingOxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal CancerWho this might be right forColorectal Cancer Prologue Research International
Testing effectiveness (Phase 2)Ended earlyNCT00052585What this trial is testingGefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumMucinous Adenocarcinoma of the Colon+7 more National Cancer Institute (NCI) 50
Not applicableStudy completedNCT00900094What this trial is testingUMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With CancerWho this might be right forBreast CancerColorectal CancerEsophageal Cancer+4 more University of Michigan Rogel Cancer Center 200
Testing effectiveness (Phase 2)UnknownNCT04621370What this trial is testingA Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal CancerWho this might be right forRectal CancerRectal AdenocarcinomaRectal Neoplasms Liz-Anne Lewsley 48
Early research (Phase 1)Not Yet RecruitingNCT07624214What this trial is testingStudy of LT-010391 in Participants With KRAS G12D-Mutant Solid TumorsWho this might be right forNon-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. 198
Testing effectiveness (Phase 2)Looking for participantsNCT06051695What this trial is testingEvaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionWho this might be right forSolid Tumor, AdultColorectal CancerNSCLC+17 more A2 Biotherapeutics Inc. 474
Early research (Phase 1)WithdrawnNCT01605344What this trial is testingCrossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRIWho this might be right forAdvanced Adenocarcinoma of the Colon or Rectum UNC Lineberger Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05824975What this trial is testingEvaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)Who this might be right forAdvanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more GI Innovation, Inc. 358
Testing effectiveness (Phase 2)Ended earlyNCT05714553What this trial is testingNUC-3373 in Combination With Other Agents in Patients With Advanced Solid TumoursWho this might be right forAdvanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more NuCana plc 19
Early research (Phase 1)Ended earlyNCT04234113What this trial is testingStudy of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsWho this might be right forThyroid CancerRenal Cell CarcinomaNon Small Cell Lung Cancer+16 more SOTIO Biotech AG 115
Early research (Phase 1)Looking for participantsNCT05433142What this trial is testingStudy of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell Carcinoma Xencor, Inc. 307
Not applicableApproved For MarketingNCT04100694What this trial is testingEarly Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid TumorWho this might be right forNRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more Merus B.V.
Testing effectiveness (Phase 2)Study completedNCT00814619What this trial is testingCapecitabine and Radiation Therapy With or Without Panitumumab in Treating Patients With Advanced Rectal CancerWho this might be right forColorectal Cancer Swiss Cancer Institute 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT07023731What this trial is testingEvaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationWho this might be right forKRAS G12D MutationAdvanced Solid Cancer Arvinas Inc. 76
Early research (Phase 1)Not Yet RecruitingNCT07566897What this trial is testingA Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With Ruxolitinib in Patients With Advanced Solid TumorsWho this might be right forRenal Carcinoma MetastaticPancreatic Adenocarcinoma MetastaticPancreatic Adenocarcinoma+1 more Philogen S.p.A. 96
Not applicableStudy completedNCT00040820What this trial is testingOxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal CancerWho this might be right forColorectal Cancer Roswell Park Cancer Institute
Early research (Phase 1)Study completedNCT03752398What this trial is testingXmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)Who this might be right forMelanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more Xencor, Inc. 198